A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019)

A Double-Blind, Multicenter, Placebo-Controlled Study of MK0777 Gel Extrusion Module (GEM) 1.5 mg b.i.d. in the Treatment of Outpatients With Generalized Anxiety Disorder

The study will look at the effectiveness of MK0777 in patients with Generalized Anxiety Disorder.

Inclusion Criteria:

• Male or Female
• Current diagnosis of Generalized Anxiety Disorder
• Age 18 - 70

Exclusion Criteria:

• Women who are pregnant, or breast-feeding
• Use of illicit drugs
• History of drug or alcohol dependence